Quarterly report pursuant to Section 13 or 15(d)

Note 22 - Segment Information

v3.19.2
Note 22 - Segment Information
6 Months Ended
Jun. 30, 2019
Notes  
Note 22 - Segment Information

Note 22 – Segment Information

 

The Company is operating, acquisition, and investment business. Subsidiaries in which the Company has a controlling financial interest are consolidated. The Company has determined that there are two reportable segments; 1) the cannabis and medical marijuana segment which includes the fair value of securities investments in GW Pharmaceuticals Plc. (GWPH), KushCo. Holdings, Inc. (KSHB), previously Kush Bottles, Inc., Generation Alpha, Inc. (GNAL), previously Solis Tek, Inc., and GB Sciences, Inc. (GBLX) stock, the cost basis of membership interests of Electrum, the contractual interest in the Electrum legal recovery, the fair value of convertible notes receivable and accrued interest from NeuCourt, the notes receivable from G Farma, the contractual interest in the G Farma legal recovery, the equity in G Farma Equity Entities, finance leases to G Farma and finance leases to Pueblo West, and the operation of subsidiaries in the cannabis and medical marijuana sector, and 2) the Company’s legacy investment in WCI which works with business park owners, governmental centers, and apartment complexes to reduce their facility related operating costs. The Company also had a certain small cancer-related legacy investment until March 2018 and an investment in note receivable from a non-affiliated party that is included in the Corporate and Eliminations section below.

 

 

 

Cannabis and Medical Marijuana Segment

 

Facility Operations Related

 

Corporate and Eliminations

 

Consolidated

Three months ended June 30, 2019

 

 

 

 

 

 

 

 

Net revenue

$

12,162

$

1,017,587

$

-

$

1,029,749

Operating income (loss)

 

(84,695)

 

40,707

 

(242,350)

 

(286,338)

Interest income

 

982

 

3

 

21,899

 

22,884

Interest expense

 

-

 

5,851

 

-

 

5,851

Property additions

 

-

 

-

 

-

 

-

Depreciation and amortization

 

-

 

(2,714)

 

2,932

 

218

 

 

 

 

 

 

 

 

 

Three months ended June 30, 2018

 

 

 

 

 

 

 

 

Net revenue

$

336,604

$

894,656

$

-

$

1,231,290

Operating income (loss)

 

92,273

 

(4,295)

 

(272,794)

 

(184,816)

Interest income

 

20,488

 

1

 

23,031

 

43,520

Interest expense

 

181

 

4,729

 

(1,039)

 

3,871

Property additions

 

-

 

-

 

2,399

 

2,399

Depreciation and amortization

 

-

 

2,593

 

1,763

 

4,356

 

 

 

Cannabis and

Medical

Marijuana

Segment

 

Facility

Operations

Related

 

Corporate

and

Eliminations

 

Consolidated

Six months ended June 30, 2019

 

 

 

 

 

 

 

 

Net revenue

$

132,252

$

1,973,493

$

-

$

2,105,745

Operating income (loss)

 

(696,392)

 

57,886

 

(504,074)

 

(1,142,580)

Interest income

 

21,628

 

6

 

43,830

 

65,464

Interest expense

 

-

 

10,375

 

-

 

10,375

Property additions

 

-

 

8,159

 

-

 

8,159

Depreciation and amortization

 

-

 

5,306

 

5,864

 

11,170

Total assets

 

2,859,528

 

1,726,522

 

1,071,868

 

5,657,918

 

 

 

 

 

 

 

 

 

Six months ended June 30, 2018

 

 

 

 

 

 

 

 

Net revenue

$

497,132

$

1,750,327

$

-

$

2,247,459

Operating income (loss)

 

133,869

 

22,193

 

(560,949)

 

(404,887)

Interest income

 

17,322

 

1

 

65,263

 

82,586

Interest expense

 

181

 

9,991

 

(2,173)

 

7,999

Property additions

 

-

 

-

 

2,399

 

2,399

Depreciation and amortization

 

-

 

5,185

 

3,471

 

8,656

Total assets

 

3,600,349

 

1,147,566

 

2,648,685

 

7,396,600

 

 

The following table reconciles operating segments and corporate-unallocated operating income (loss) to consolidated income before income taxes, as presented in the unaudited condensed consolidated income statements:

 

 

 

Three Months Ended

June 30,

 

Six Months Ended

June 30

 

 

2019

 

2018

 

2019

 

2018

Operating loss

$

(286,338)

$

(184,816)

$

(1,142,580)

$

(404,887)

Gain (loss) on investments

 

(132,088)

 

66,606

 

(1,701,969)

 

118,197

Interest income

 

22,884

 

43,520

 

65,464

 

82,586

Interest expense

 

(5,851)

 

(3,871)

 

(10,375)

 

(7,999)

Gain on equipment disposals

 

1,500

 

-

 

1,500

 

-

Other income

 

11,340

 

-

 

11,340

 

2,380

 

 

 

 

 

 

 

 

 

Income before income taxes

$

(388,553)

$

(133,541)

$

(2,776,620)

$

(209,723)